[1] GLAUSER F L.Variant asthma[J].Ann Allergy,1972,30(8):457-459.
[2] Hannaway P J Hopper G D.Cough variant asthma in children[J].JAMA,1982,247(2):206-208.
[3] LI X C,LI J,RAO X L,et al.A case report of tracheal inflammatory myofibroblastic tumor in a 34-week pregnant woman misdiagnosed with asthma[J].Medicine(Baltimore),2017,96(33):e7872.
[4] LAVOIE J P,LECLERE M,RODRIGUES N,et al.Efficacy of inhaled budesonide for the treatment of severe equine asthma[J].Equine Vet J,2019,51(3):401-407.
[5] CORRAO W M.Pearls and pitfalls in the diagnosis of cough variant asthma[J].Allergy Asthma Proc,2018,39(6):466-467.
[6] URYASJEV M O,PONOMAREVA I V,BHAR M,et al.[The cough variant asthma] [J].Ter Arkh,2020,92(3):98-101.
[7] MIWA N,NAGANO T,OHNISHI H,et al.An open-label,multi-institutional,randomized study to evaluate the additive effect of a leukotriene receptor antagonist on cough score in pa-tients with cough-variant asthma being treated with inhaled corti-costeroids[J].Kobe J Med Sci,2018,64(4):E134-E139.
[8] CHEN X,ARUMUGAM T V,CHENG Y L,et al.Combination therapy with low-dose IVIG and a C1-esterase inhibitor ameliorates brain damage and functional deficits in experimental ischemic stroke[J].Neuromolecular Med,2018,20(1):63-72.
[9] OBASE Y,SHIMODA T,KISHIKAWA R,et al.Trigger of bronchial hyperresponsiveness development may not always need eosinophilic airway inflammation in very early stage of asthma[J].Allergy Rhinol(Providence),2016,7(1):1-7.
[10] DE DIEGO A,MARTÍNEZ E,PERPIÑÁ M,et al.Airway inflammation and cough sensitivity in cough-variant asthma[J].Allergy,2005,60(11):1407-1411.
[11] ZHANG Y X,LIU Y,XUE Y,et al.Correlational study on atmospheric concentrations of fine particulate matter and children cough variant asthma[J].EUR REV MED PHARMACO,2016,20(12):26-50.
[12] BOSKABADY M H,NEAMATI A.Improvement of tracheal responsiveness and Th1/Th2 balance in a rat model of asthma,treated with portulaca oleracea[J].Altern Rher Health Med,2019,2019:5718.
[13] BRITT R D,THOMPSON M A,SASSE S K,et al.Th1 cytokines TNF-α and IFN-γ promote corticosteroid resistance in developing human airway smooth muscle[J].Am J Physiol,2019,316(1):L71-L81.
[14] KANEMITSU Y,MATSUMOTO H,OSMAN N,et al."Cold air" and/or "talking" as cough triggers,a sign for the diagnosis of cough variant asthma[J].Respir Investig,2016,54(6):413-418.
[15] 付克功.小儿咳嗽变异性哮喘的临床特征及其发病影响因素分析[J].中国妇幼保健,2020,35(3):483-486.
[16] CHEN F J,HUANG X Y,LIN G P,et al.Validity of fractional exhaled nitric oxide and small airway function indices in diagnosis of cough-variant asthma[J].J Asthma,2017,55(7):750-755.
[17] DIANE L M,SCOTT E T,THOMAS F.Cough variant asthma:lessons learned from deep inspirations[J].Lung,2012,190(1):17-22.
[18] CIRILLO I,KLERSY C,MARSEGLIA G L,et al.Role of FEF 25%-75% as a predictor of bronchial hyperreactivity in allergic patients[J].Ann Allergy Asthma Immunol,2006,96(5):692-700.
[19] 张皓.婴幼儿肺功能检测及气道反应性测定[J].临床儿科杂志,2012,30(8):701-703.
[20] SHIMODA T,OBASE Y,KISHIKAWA R,et al.The fractional exhaled nitric oxide and serum high sensitivity C-reactive protein levels in cough variant asthma and typical bronchial asthma[J].Allergol Int,2013,62(2):251-257.
[21] SONG W J,KIM H J,SHIM J S,et al.Diagnostic accuracy of fractional exhaled nitric oxide measurement in predicting coughvariant asthma and eosinophilic bronchitis in adults with chronic cough:a systematic review and meta-analysis[J].J Allergy Clin Immunol,2017,140(3):701-709.
[22] DWEIK R A,BOGGS P B,ERZURUM S C,et al.An official ATS clinical practice guideline:interpretation of exhaled nitric oxide levels(FENO) for clinical applications[J].Am J Respir Crit Care Med,2011,184(5):602-615.
[23] 广州呼吸疾病研究所,首都医科大学附属北京儿童医院,卫生部中日友好医院,等.中国人呼出气一氧化氮(FeNO)正常值全国多中心研究[J].中华全科医学,2013,11(3):341-345.
[24] SHIMODA T,IMAOKA M,KISHIKAWA R,et al.Usefulness of high-sensitivity C-reactive protein as a marker of airway inflammation in cough variant and bronchial asthma[J].J Allergy Clin Immunol,2008,121(2):5198.
[25] NOBATA K,FUJIMURA M,TSUJI H,et al.Longitudinal changes of pulmonary function and bronchial responsiveness in cough variant asthma treated with bronchodilators alone[J].Allergy Asthma Proc,2006,27(6):479-485.
[26] 雷旭艳.儿童咳嗽变异性哮喘过敏原及血清IgE定量检测研究[J].现代诊断与治疗,2018,29(15):2472-2474.
[27] SHIMODA T T,KISHIKAWA R R,SHOJI S S,et al.Efficacy of airway antiinflammatory treatments evaluated with airway inflammation markers in patients with cough variant asthma:budesonide versus montelukast[J].J Allergy Clin Immunol,2006,117(2):S176.
[28] 廖述霞,谢东梅,罗双红,等.不同方式吸入糖皮质激素对咳嗽变异性哮喘儿童肺功能和炎性介质的影响[J].吉林医学,2020,41(2):306-309.
[29] WANG X,TANG G,RESPIRATION D O.Efficacy of terbutaline aerosol inhalation combined with budesonide suspension in the treatment of cough variant asthma[J].China Health Standard Management,2017,8(18):86-87.
[30] KEAST S L,THOMPSON D,FARMER K,et al.Impact of a prior authorization policy for montelukast on clinical outcomes for asthma and allergic rhinitis among children and adolescents in a state medicaid program[J].J Manag Care Pharm,2014,20(6):612-621.
[31] 朱晓弘,涂金伟,代继宏.丙酸氟替卡松、孟鲁斯特钠、酮替芬治疗儿童咳嗽变异性哮喘的临床疗效观察[J].中国当代儿科杂志,2019,21(4):393-398.
[32] 张前明,李劲松,段宝珍.沙美特罗/丙酸氟替卡松联合孟鲁司特治疗儿童咳嗽变异性哮喘的临床观察[J].安徽医药,2013,17(8):1379-1380.
[33] ZHANG Y,ZENG K,WANG J,et al.Identifying the antiasth-matic target of doxofylline using immobilized β2-adrenoceptor based high-performance affinity chromatography and site-directed molecular docking[J].J Mol Recognit,2016,29(10):492-498.
[34] 刘琳砚,闫军,周霞,等.盐酸西替利嗪滴剂联合孟鲁司特钠咀嚼片治疗儿童咳嗽变异性哮喘的临床研究[J].中国临床药理学杂志,2021,37(3):238-240,245.
[35] 张静.酮替芬治疗儿童咳嗽变异性哮喘的效果观察[J].北方药学,2020,17(1):81-82.
[36] WANG X P,YANG L D,ZHOU J F.Montelukast and budesonide combination for children with chronic cough-variant asthma[J].Medicine(Baltimore),2018,97(30):e11557.
[37] 戴天生.儿童咳嗽变异性哮喘 42 例临床分析[J].实用临床医学,2016,17(11):60-61.
[38] 付克功.小儿咳嗽变异性哮喘的临床特征及其发病影响因素分析[J].中国妇幼保健,2020,35(3):483-486.
[39] COOKSON W O,YOUNG R P,SANDFORD A J,et al.Maternal inheritance of atopic IgE responsiveness on chromosome-11q[J].Lancet,1992,340(8816):381-384.
[40] 王翠霞.小儿咳嗽变异性哮喘与肺炎支原体感染的关系及大原内酯类药物治疗的效果[J].临床肺科杂志,2015,20(3):520-522. |
